U.S. Smart Gastroenterology Devices Market

Market Outlook

By 2035, the U.S. Smart Gastroenterology Devices Market is projected to reach approximately USD 16.32 billion, expanding at an aggressive CAGR of 11.80% during the forecast period 2026–2035. The market is estimated at approximately USD 5.35 billion in 2025, following expansion from approximately USD 3.08 billion in 2021 to USD 4.74 billion in 2024. Historical analysis covers 2021–2024, the base year is 2025, and all values in this report are expressed in USD billions.

For the purpose of this report, smart gastroenterology devices comprise gastroenterology technologies in which conventional diagnostic or therapeutic hardware is materially enhanced through artificial intelligence, computer vision, digital image processing, wireless capsule technology, embedded sensors, connected analytics, advanced visualization, cloud-enabled workflow, robotic assistance, or intelligent physiologic measurement. The scope therefore extends beyond basic endoscopes while avoiding the artificial inflation that would result from classifying the entire conventional GI device universe as “smart.”

The U.S. market is moving from conventional visualization-driven gastroenterology toward data-assisted detection, digitally guided intervention and connected diagnostic workflows. Artificial intelligence-assisted colonoscopy is already shifting how health systems evaluate adenoma detection and quality consistency. Capsule endoscopy is extending visualization beyond areas easily reached with conventional scopes. Advanced endoscopic imaging is improving mucosal characterization. Sensor-enabled motility and reflux platforms are generating quantitative physiologic data, while drug-free ingestible devices are opening new therapeutic concepts. Robotic and mechanically assisted endoluminal systems could eventually enable complex procedures that currently require exceptionally advanced manual endoscopic skill.

Demand is reinforced by the scale of gastrointestinal disease in the United States. Digestive diseases affect tens of millions of Americans, while colorectal cancer remains a major source of cancer mortality and healthcare expenditure. Screening guidelines now encompass adults beginning at age 45 for average-risk colorectal cancer screening, enlarging the addressable screening pool. At the same time, a substantial number of screening-eligible Americans remain unscreened or not current with recommended testing, leaving room for further procedure growth.

The addressable market is also supported by a large provider infrastructure. Thousands of U.S. hospitals, ambulatory surgical centers, academic endoscopy units and gastroenterology practices perform diagnostic and therapeutic procedures every year. Gastroenterology is particularly important to the outpatient procedural economy because colonoscopy and upper gastrointestinal endoscopy are among the most frequently performed procedures in ambulatory settings.

Smart gastroenterology procurement is consequently moving beyond a conventional capital-equipment decision. Health systems increasingly evaluate whether a technology can improve lesion detection, standardize quality across physicians, increase throughput, reduce repeat procedures, improve procedure documentation, strengthen reimbursement capture, support accreditation metrics, reduce staff burden, integrate with existing endoscopy towers and avoid major disruption to established workflows.

The market is therefore entering a period in which clinical intelligence will increasingly become embedded within the GI procedure itself. By 2035, competitive advantage is expected to depend less on optical hardware in isolation and more on the combined performance of imaging, intelligence, connectivity, therapeutic capability and workflow economics.

Introduction

According to the U.S. Smart Gastroenterology Devices Market Report, gastroenterology is becoming one of the most important clinical settings for intelligent medical-device deployment because GI care combines high procedural volume, image-intensive diagnosis, preventive screening, complex therapeutic intervention and substantial opportunities for outpatient migration.

The United States provides a favorable environment for this transition. It has a large colorectal cancer screening population, extensive specialist networks, high endoscopy capacity, established Medicare and commercial reimbursement pathways, sophisticated academic medical centers and an increasingly consolidated base of gastroenterology practices and ambulatory surgery centers.

The economic structure of GI care is especially relevant. Endoscopy suites must operate at high throughput while maintaining quality standards. Procedure delays, inadequate preparation, missed lesions, inefficient room turnover, repeat examinations and documentation burdens can materially affect economics. A technology capable of generating only a modest clinical improvement may become commercially attractive if it simultaneously fits existing workflow and improves the productivity of the endoscopy unit.

Artificial intelligence illustrates this dynamic. Computer-aided detection systems can process live colonoscopy images and alert physicians to suspected lesions. These systems do not replace the endoscopist, but they can act as an additional visual layer during a procedure. The commercial proposition is therefore not simply “AI adoption.” The real proposition is whether an endoscopy organization can improve quality consistency across physicians without materially extending procedure time or creating distracting false alerts.

Capsule endoscopy addresses a different workflow problem. The small bowel is difficult to examine comprehensively with conventional upper and lower endoscopy. Wireless imaging capsules allow visualization while patients move through normal daily activities, creating an important diagnostic pathway for obscure gastrointestinal bleeding, suspected Crohn’s disease and selected small-bowel disorders. The next competitive phase is moving toward higher image quality, panoramic visualization, improved software interpretation and more efficient review.

Smart physiologic diagnostics are also increasingly relevant. Gastroesophageal reflux, constipation, motility disorders, dysphagia and functional gastrointestinal conditions often require information that cannot be obtained from conventional structural imaging alone. High-resolution manometry, wireless pH monitoring, impedance measurement and connected motility platforms can generate quantitative information that supports treatment decisions.

Another emerging category is intelligent therapeutic gastroenterology. Advanced endoscopic resection, endoscopic suturing, tissue ablation, bariatric endoscopy and natural-orifice intervention require greater control and precision than routine diagnostic procedures. Robotic endoluminal systems remain early in their U.S. development cycle, but their strategic importance is significant because they could expand the number of physicians able to perform technically difficult procedures.

The result is a heterogeneous but strategically coherent market. Smart gastroenterology devices do not represent one device class. They represent the migration of GI care from manually interpreted hardware toward intelligent procedural ecosystems.

Key Market Drivers: What’s Fueling the U.S. Smart Gastroenterology Devices Market Boom?

The first major driver is the large burden of gastrointestinal disease and colorectal cancer screening demand. Digestive diseases collectively affect tens of millions of Americans. Colorectal cancer alone generates approximately 159,000 new diagnoses annually in the current U.S. disease environment, while screening recommendations include average-risk adults beginning at age 45. The size of this population creates a recurring requirement for technologies that improve screening quality, diagnostic accuracy and procedural efficiency.

A particularly important commercial factor is the remaining screening gap. A meaningful proportion of U.S. adults aged 45–75 are still not current with colorectal cancer screening, and millions have never been screened. Increased screening penetration does not translate exclusively into colonoscopy because stool-based screening also plays an important role, but positive non-invasive tests frequently create downstream colonoscopy demand. Smart colonoscopy technologies therefore participate in a broader screening ecosystem rather than competing solely within procedure rooms.

The second driver is the economic importance of adenoma detection and quality standardization. Colonoscopy quality can vary by physician, fatigue, withdrawal technique, lesion morphology, preparation quality and procedural environment. Flat lesions and sessile serrated lesions can be difficult to identify. Artificial intelligence-assisted detection systems are being developed to reduce variation by continuously analyzing the live endoscopic video stream.

For large U.S. gastroenterology organizations, the strategic value of AI may therefore come from reducing performance dispersion across a physician network. A platform that helps an organization deliver more consistent examinations across dozens or hundreds of endoscopists may have greater enterprise value than one positioned merely as a premium feature for individual physicians.

The third driver is the migration of GI procedures toward ambulatory surgical centers. The U.S. had more than 6,400 Medicare-certified ASCs by the end of 2024, and colonoscopy and upper-GI endoscopy are among the most common procedures performed in these facilities. ASC economics are based on high utilization, rapid room turnover, controlled staffing costs and predictable procedure duration. Smart devices therefore gain a major commercial advantage when they enhance quality without slowing the procedure.

ASCs also create different procurement requirements from tertiary hospitals. They frequently prefer technologies that can be added to existing towers, require limited physical footprint, have predictable service requirements and support straightforward per-procedure economics. Cloud-delivered or modular intelligence may be attractive because it can reduce dependence on major capital replacement cycles.

The fourth driver is the shortage and productivity pressure affecting gastroenterology specialists and clinical staff. The U.S. gastroenterology workforce must manage an expanding screening population, an aging population with chronic GI conditions and increasing demand for advanced procedures. Intelligent systems capable of assisting image review, documentation, procedure quality assessment or patient preparation can improve the productivity of highly specialized clinical labor.

The fifth driver is the shift from diagnostic endoscopy toward advanced therapeutic endoscopy. Endoscopic mucosal resection, endoscopic submucosal dissection, full-thickness resection, endoscopic suturing, bariatric endoscopy and other advanced techniques can eliminate or reduce the need for more invasive surgery in selected patients. However, these procedures require advanced training and technical dexterity. Robotic assistance, enhanced visualization and intelligent navigation could reduce technical barriers and improve procedural reproducibility.

The sixth driver is the maturation of connected and cloud-enabled medical devices. Gastroenterology has historically relied on equipment located within the endoscopy room, but connected platforms allow software updates, remote analytics, fleet management and enterprise data aggregation. Cloud connectivity can potentially reduce hardware dependence and accelerate software deployment across large health systems.

However, cloud adoption also creates new procurement questions involving cybersecurity, network reliability, data governance, software validation and integration with hospital IT infrastructure. Vendors that can address these concerns at enterprise scale will have an advantage.

The seventh driver is hospital capital-equipment replacement and platform standardization. U.S. health systems increasingly negotiate endoscopy equipment across multiple hospitals and outpatient facilities. Once a health system standardizes on a major imaging architecture, interoperability can significantly affect subsequent purchasing. Manufacturers are therefore competing to make intelligent functionality part of the broader endoscopy ecosystem rather than a disconnected accessory.

The eighth driver is the growing clinical relevance of minimally invasive, drug-free and sensor-based GI management. Smart ingestible devices demonstrate how the market can move beyond visualization. Programmable capsules, wireless sensing platforms and digitally monitored treatments create possibilities for constipation, motility disorders and other conditions in which conventional pharmaceutical therapy may be inadequate or poorly tolerated.

Taken together, these forces support a market in which value is migrating toward technologies that improve detection, consistency, efficiency, connectivity or minimally invasive treatment.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Artificial intelligence-assisted endoscopy represents the most visible innovation frontier. The U.S. now has multiple computer-aided polyp detection technologies, creating a genuine competitive category rather than a single-product market. GI Genius helped establish the commercial pathway for real-time computer-assisted colorectal lesion detection, while systems such as CAD EYE, SKOUT, EndoScreener and CADDIE have broadened the competitive landscape.

The next innovation cycle will move beyond simply placing a box around a suspected polyp. Manufacturers are developing technologies that can support lesion characterization, procedural quality measurement, documentation, anatomical landmark recognition and decision support. Over time, AI could increasingly function as an intelligent procedural layer rather than a single-purpose detection algorithm.

Cloud-based AI is particularly important. Conventional CADe systems typically rely on dedicated local processing hardware. Cloud-enabled architectures create the possibility of faster software iteration, centralized deployment and subscription-oriented purchasing. For large integrated delivery networks and GI practice platforms, this may simplify deployment across multiple facilities. The tradeoff is that cloud performance, cybersecurity and connectivity become part of the medical-device value proposition.

Advanced visualization remains another major innovation area. High-definition imaging, 4K visualization, narrow-band imaging, linked-color imaging and other enhanced visualization approaches can improve mucosal differentiation. When these modalities are combined with computer vision, the platform can potentially provide both superior human visualization and machine-assisted interpretation.

Capsule endoscopy is moving toward broader visualization, improved battery management, higher frame rates and more advanced interpretation software. Small-bowel capsule endoscopy already occupies an established diagnostic role, but smart capsule technology is likely to expand through AI-assisted video review, improved localization and eventually more sophisticated sensing.

Ingestible therapy represents a fundamentally different innovation path. Programmable mechanical capsules for chronic idiopathic constipation demonstrate that an ingestible device can act therapeutically rather than only record images or physiologic signals. These technologies are important because they combine hardware, embedded programming, patient-use workflow and recurring disposable economics.

Robotic endoluminal surgery is one of the highest-upside long-term opportunities. Systems under U.S. clinical evaluation are designed to provide surgical-style dexterity through natural body openings. If regulatory authorization and clinical adoption follow, these platforms could reshape management of selected colorectal and gastrointestinal lesions by allowing complex resections without conventional abdominal surgery.

Digital endoscopic ultrasound is another strategically important field. Ultrasound-enabled endoscopy supports evaluation and intervention involving the pancreas, biliary system, gastrointestinal wall and adjacent structures. Newer approaches seek to reduce system complexity and improve compatibility with existing endoscopy environments.

Manufacturers are also competing through interoperability. The strongest future platforms are likely to connect procedural imaging, AI detection, therapeutic tools, patient information, reporting software and quality analytics. This is strategically important because hospitals increasingly prefer technologies that reduce the number of disconnected systems clinical staff must manage.

The next decade of innovation will therefore be defined by convergence. Optics, sensing, AI, robotics, therapeutics and software are increasingly becoming parts of a common gastroenterology technology architecture.

Segmentation Insights

The U.S. Smart Gastroenterology Devices Market is segmented on the basis of product category, technology type, application, end user and geography.

By Product Category

AI-Assisted Endoscopy and Intelligent Detection Systems

AI-assisted endoscopy represents the fastest-growing smart gastroenterology product category. These systems analyze live endoscopic images and provide visual or audible alerts when potentially relevant lesions are identified. Colorectal polyp detection is currently the most commercially developed use case because colonoscopy is performed at high volume and adenoma detection is an established quality metric.

This subsegment is shifting from first-generation adoption toward competitive differentiation. U.S. buyers increasingly compare sensitivity, false-alert burden, compatibility, latency, installation requirements, clinical evidence and cost per procedure. The emergence of several FDA-cleared systems is increasing purchaser negotiating leverage and should accelerate adoption among large gastroenterology groups.

Capsule Endoscopy and Smart Ingestible Devices

Capsule endoscopy and intelligent ingestible technologies form one of the most distinctive categories in the market. Wireless capsules are used primarily for small-bowel visualization when conventional endoscopy cannot provide complete anatomical access. Relevant systems include small-bowel capsule platforms, colon capsule technologies, panoramic capsule imaging and software-assisted review.

The category is expanding beyond diagnosis. Programmable ingestible devices demonstrate that smart capsules can also provide therapy. Future opportunities may include physiologic sensing, localization, targeted stimulation and multimodal gastrointestinal monitoring.

Commercial adoption is influenced by reimbursement, patient selection, capsule retention risk, interpretation time and the ability to integrate capsule data into existing clinical workflow.

Connected Advanced Visualization and Imaging Platforms

Connected imaging systems include intelligent video processors, enhanced visualization platforms, digitally integrated endoscopy towers, image-enhancement technologies and smart endoscopic ultrasound solutions.

This is one of the largest product pools by value because the segment combines premium capital equipment with recurring upgrade cycles. Health systems increasingly want imaging platforms that can support multiple future AI applications without requiring replacement of the entire endoscopy tower.

The strategic value of this category lies in installed-base control. Vendors that provide the primary visualization platform can influence subsequent purchasing of scopes, software, accessories, service contracts and advanced therapeutic technologies.

Robotic and Mechanically Assisted Endoscopic Platforms

Robotic endoscopy remains smaller commercially but has one of the highest long-term growth potentials. These technologies are designed to improve scope control, endoluminal navigation, tissue manipulation, resection and closure.

The major U.S. opportunity is not replacing routine diagnostic colonoscopy with robotics. The more compelling opportunity is enabling advanced therapeutic procedures that are currently limited by physician dexterity, training requirements or procedural complexity.

Endoscopic submucosal dissection is a particularly important use case because it can allow en bloc removal of selected lesions while potentially avoiding major surgery. If flexible endoluminal robotic systems demonstrate clinical and economic value, they could create an entirely new capital-equipment category for advanced GI centers.

Smart Physiologic Diagnostic and Therapeutic Devices

This category includes high-resolution manometry systems, wireless reflux monitoring, impedance measurement, digital motility platforms, sensor-enabled gastrointestinal diagnostics and intelligent non-pharmacologic therapeutic devices.

The segment addresses conditions including GERD, dysphagia, chronic constipation, functional GI disease and motility disorders. These disorders can generate repeated consultations and testing because symptoms do not always correlate with visible structural abnormalities.

Quantitative physiologic devices are therefore important because they provide objective information that can guide treatment. Long-term growth will be supported by smaller sensors, wireless data transmission, automated interpretation and more patient-friendly diagnostic pathways.

By Technology Type

Artificial Intelligence and Computer Vision

AI and computer vision represent the most disruptive technology segment. Current commercial use is concentrated in lesion detection during colonoscopy, but the longer-term opportunity includes lesion characterization, procedure-quality monitoring, automated reporting, therapeutic planning and risk stratification.

Adoption will increasingly depend on evidence demonstrating that AI adds value beyond incremental detection. U.S. purchasers will examine whether improved detection translates into clinically meaningful outcomes and whether implementation improves or complicates physician workflow.

The market will consequently favor systems that minimize unnecessary alerts, integrate transparently into existing procedures and provide measurable quality data at the physician and facility level.

Wireless Capsule Imaging and Ingestible Electronics

Wireless capsule technology eliminates the need for a tethered scope for selected diagnostic or therapeutic use cases. Advances in miniature cameras, low-power electronics, wireless transmission, battery technology and embedded programming are expanding possibilities within this segment.

Small-bowel imaging remains the commercial foundation. Over the forecast period, AI-assisted reading and intelligent navigation of large image datasets should reduce interpretation burden and make capsule diagnostics more scalable.

Ingestible therapeutic devices could create recurring revenue streams because disposable capsules are repeatedly consumed rather than purchased once as capital equipment.

Cloud-Connected Analytics and Interoperability

Cloud connectivity is becoming an important differentiator in gastroenterology. Software can be updated remotely, procedural information can be aggregated across sites and centralized dashboards can support enterprise quality management.

Large GI groups may be particularly receptive because many operate multiple endoscopy facilities. A cloud architecture can give executive leadership visibility into procedure quality, device utilization and physician performance across geographically dispersed sites.

However, medical-device cloud deployment must meet stringent cybersecurity, privacy, latency and reliability requirements. Hospitals are therefore likely to concentrate purchasing among vendors with credible enterprise IT capabilities.

Robotic, Mechatronic and Assisted Navigation Technology

This segment encompasses motorized scope control, robotic manipulation, flexible robotic platforms and intelligent navigation technologies.

Adoption will initially concentrate in academic medical centers and high-volume advanced-endoscopy programs because these institutions have the specialists, procedural complexity and research infrastructure required to evaluate new robotic platforms.

The commercial inflection point will occur if robotic assistance allows procedures currently performed surgically to be completed endoluminally with lower utilization, shorter recovery or improved patient selection.

Sensor-Based Physiologic Measurement and Smart Therapy

Sensor-enabled technology includes pressure measurement, pH sensing, impedance, motility assessment and programmable mechanical stimulation.

Unlike image-based GI devices, these technologies generate physiologic information or directly influence GI function. They are particularly relevant to functional disorders where conventional imaging may be normal.

The value proposition is closely connected to diagnostic confidence. Devices that help physicians avoid repeated empirical treatment and establish an objective mechanism for symptoms can improve the efficiency of the diagnostic pathway.

By Application

Colorectal Cancer Screening and Polyp Detection

Colorectal screening is the largest application for smart gastroenterology devices because of procedure volume, the scale of the screening-eligible population and the clinical importance of adenoma detection.

AI-assisted colonoscopy is likely to experience substantial penetration during the forecast period. The competitive focus will shift toward identifying clinically meaningful lesions, improving detection of difficult morphology and supporting quality assurance.

The segment also benefits from the expansion of screening to adults beginning at age 45 and from downstream colonoscopy following abnormal stool-based screening.

Inflammatory Bowel Disease and Small-Bowel Evaluation

Crohn’s disease and other small-bowel conditions represent a major application for capsule imaging and advanced endoscopy.

Capsule technologies can visualize mucosal areas that are difficult to examine using conventional gastroscopy or colonoscopy. Smart image interpretation can reduce the time required to review long capsule studies and support more standardized identification of abnormalities.

IBD also creates opportunities for AI-based endoscopic assessment because treatment decisions increasingly depend on objective disease activity and mucosal healing.

Upper-GI, Hepatobiliary and Pancreatic Disease

Smart devices are increasingly relevant to esophageal, gastric, biliary and pancreatic care. Advanced endoscopic imaging can support detection and characterization of upper-GI abnormalities, while digital endoscopic ultrasound and intelligent guidance are important for pancreatic and biliary assessment.

AI adoption in upper-GI endoscopy may proceed differently from colorectal applications because disease prevalence, lesion patterns and established quality metrics differ. Quality-monitoring and blind-spot detection may become commercially important even when incremental lesion detection among expert endoscopists is modest.

GERD, Motility and Functional Gastrointestinal Disorders

Functional GI conditions are an attractive application because they often require physiologic rather than purely anatomical evaluation.

Wireless pH monitoring, high-resolution manometry, impedance and motility systems can support diagnosis of GERD, swallowing disorders and other functional abnormalities. Smart therapeutic capsules provide an emerging alternative for selected constipation patients who do not obtain adequate relief from conventional approaches.

This application is likely to grow as patient pathways become more data-driven and physicians seek objective evidence before escalating treatment.

Advanced Therapeutic Endoscopy and Endoluminal Intervention

Therapeutic endoscopy is expected to become one of the fastest-growing applications. Relevant procedures include complex polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection, tissue closure, suturing, ablation and selected bariatric procedures.

Intelligent imaging helps define lesions, while robotic assistance may eventually expand physician capability. The economic appeal is significant when endoscopic treatment can substitute for surgery or reduce hospitalization.

Academic medical centers will remain critical early adopters, but successful technologies can migrate to major regional health systems as physician training and procedural standardization improve.

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks account for the largest share of market value because they purchase premium endoscopy systems, advanced imaging, EUS platforms, AI infrastructure and therapeutic technologies.

Large health systems increasingly negotiate enterprise contracts covering multiple hospitals and outpatient centers. They evaluate equipment not only through acquisition cost but through service reliability, physician preference, total procedure economics, cybersecurity, interoperability and long-term platform road maps.

Systems that can deploy intelligent functionality across an existing installed base have a particularly strong competitive advantage.

Ambulatory Surgery Centers

ASCs represent the most strategically important growth setting. Gastroenterology is already one of the major procedural specialties within the U.S. ASC ecosystem.

These facilities prioritize throughput, compact equipment, predictable costs and rapid implementation. AI polyp-detection systems can be attractive where they can be added to existing colonoscopy workflows without materially increasing procedure duration.

The rapid expansion and consolidation of GI-focused ASCs also creates an opportunity for vendors to negotiate network-level contracts rather than sell site by site.

Academic Medical Centers and Advanced Gastroenterology Centers

Academic centers are the primary early-adoption environment for robotic endoscopy, advanced therapeutic procedures, new AI applications and complex imaging technologies.

These institutions conduct trials, generate evidence, develop training protocols and influence national clinical adoption. Manufacturers often use leading academic programs as reference sites before expanding into community care.

Although the number of centers is comparatively small, the strategic influence of this segment is disproportionately high.

Gastroenterology Practices and Physician Offices

Large gastroenterology groups have become increasingly important buyers as the specialty consolidates. Many groups operate physician clinics, infusion centers and affiliated ASCs, giving them influence over multiple stages of the GI care pathway.

Smart physiologic diagnostics, capsule endoscopy and connected software are especially relevant in this setting because they can extend diagnostic capability outside the hospital.

Procurement decisions are highly sensitive to reimbursement, staff requirements and physician productivity.

Home-Based and Remote Diagnostic/Therapeutic Users

Home-oriented GI technology currently represents a smaller portion of market value but could expand rapidly.

Wireless monitoring, capsule diagnostics and ingestible therapeutic devices allow portions of the care pathway to occur outside hospitals and procedural facilities. This can improve convenience and reduce facility utilization.

The strongest long-term opportunities will involve technologies that combine a physical device with remote clinician oversight, automated data interpretation and secure transfer of results.

Regional Insights: Where the Market is Growing Fastest

The U.S. Smart Gastroenterology Devices Market is geographically segmented into the South, West, Northeast and Midwest. Regional performance differs according to population size, age distribution, colorectal screening volumes, gastroenterologist density, ASC penetration, hospital concentration, academic medical-center presence, technology adoption and availability of advanced therapeutic endoscopy.

The South is the largest regional market in 2025, while the West is expected to record the fastest CAGR through 2035. The Northeast remains disproportionately important for clinical innovation and advanced endoscopy, while the Midwest offers a large installed base of mature health systems and significant opportunities for enterprise modernization.

South

The South represents approximately USD 1.82 billion of the U.S. market in 2025 and is projected to reach about USD 5.30 billion by 2035, corresponding to an estimated regional CAGR of approximately 11.3%.

The region comprises Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma and Texas, together with the District of Columbia for healthcare-market analysis.

Texas and Florida are the two most important smart gastroenterology device markets in the region. Texas combines a very large population with major healthcare clusters in Houston, Dallas-Fort Worth, Austin and San Antonio. Large integrated delivery networks, academic centers and independent GI groups create demand for advanced endoscopy towers, capsule systems, AI colonoscopy and therapeutic endoscopy.

Florida is particularly important because of its large older population and extensive ambulatory-care infrastructure. Colorectal cancer screening, chronic GI disease, pancreatic and biliary care and high-volume outpatient endoscopy create an attractive environment for intelligent visualization and workflow-enhancement technologies.

North Carolina has become a strategically important market because of population growth, strong academic centers and expanding healthcare networks. Charlotte, Raleigh-Durham and the Triad support a combination of tertiary medicine and high-volume community gastroenterology.

Georgia and Tennessee have major metropolitan referral markets centered around Atlanta and Nashville. Nashville is additionally important because of its healthcare-services ecosystem, which can influence the commercialization and scaling of multi-site GI practices.

Virginia and Maryland benefit from dense provider markets, strong health systems and proximity to major academic and federal research institutions. Delaware is smaller in absolute value but participates in the highly integrated Mid-Atlantic provider market.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia and Oklahoma have comparatively smaller smart-device markets, but several carry substantial gastrointestinal and colorectal disease burden. Rural access constraints create opportunities for technologies that improve diagnostic reach, physician productivity and referral efficiency.

The South will remain the largest U.S. region because it combines population growth, aging demographics, strong ASC economics and expanding specialty-care infrastructure. Manufacturers that can offer scalable AI pricing, strong field service and solutions suitable for both high-volume urban centers and smaller regional facilities are likely to perform well.

West

The West represents approximately USD 1.39 billion in 2025 and is projected to reach about USD 4.60 billion by 2035, translating into an estimated CAGR of approximately 12.7%, the fastest among the four U.S. regions.

The West includes California, Washington, Oregon, Nevada, Arizona, Utah, Colorado, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii.

California is the dominant state market. Its large population, sophisticated hospital systems, high concentration of academic medicine, digital-health ecosystem and willingness to evaluate emerging technology make it a critical launch environment for intelligent gastroenterology devices.

Major markets including Los Angeles, San Francisco, San Diego and Sacramento support extensive endoscopy capacity and advanced subspecialty care. California is especially important for AI, connected care and technologies that integrate medical devices with enterprise software.

Arizona and Nevada are high-growth opportunities because of population migration and aging demographics. Phoenix, Scottsdale and Las Vegas have expanding hospital and specialty-care networks, creating demand for screening colonoscopy, therapeutic endoscopy and motility diagnostics. Arizona is also strategically relevant to early robotic and advanced endoscopy research.

Washington and Oregon are attractive for digitally connected solutions due to concentrated integrated health systems and strong technology adoption. Seattle and Portland function as regional referral centers for complex GI care.

Colorado and Utah combine fast-growing populations with sophisticated integrated delivery systems. Denver and Salt Lake City are important markets for advanced procedural technologies and enterprise platform purchasing.

New Mexico, Idaho, Montana, Wyoming and Alaska present smaller installed bases and substantial geographic access challenges. Technologies that reduce the need for repeat travel, streamline specialist review or enable remote interpretation can offer disproportionate value in these markets.

Hawaii is small by total market size but has distinct logistical requirements because equipment service, consumables distribution and specialist access are affected by geography.

The West’s faster growth is expected to come from AI adoption, cloud-connected endoscopy, robotic clinical development, smart capsule platforms and rapid diffusion of digitally enabled care models.

Northeast

The Northeast represents approximately USD 1.23 billion in 2025 and is projected to reach approximately USD 3.62 billion by 2035, implying an estimated CAGR of roughly 11.4%.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York and Pennsylvania.

New York is the largest state market in the region. New York City contains one of the country’s densest concentrations of academic medical centers, specialist practices and high-complexity procedure programs. Upstate markets additionally support major regional health systems and referral networks.

Massachusetts has unusually high strategic importance relative to its population. Boston’s academic ecosystem plays a major role in clinical research, medtech development and evaluation of advanced endoscopic technologies. AI, capsule imaging, digital diagnostics and endoluminal robotics are particularly relevant to this market.

Pennsylvania provides a large and diversified market anchored by Philadelphia, Pittsburgh and extensive regional health systems. The state combines academic medicine with a substantial community-hospital and outpatient-care footprint.

New Jersey benefits from population density, strong commercial insurance coverage and integration with the New York and Philadelphia healthcare markets. Connecticut similarly participates in a high-value Northeast corridor with significant specialist density.

Rhode Island, New Hampshire, Maine and Vermont are smaller state markets but are strategically relevant for technologies capable of extending subspecialty expertise across geographically dispersed populations.

Procurement in the Northeast is often evidence-intensive. Hospitals and academic centers frequently require strong clinical data, cybersecurity review, interoperability evaluation and clear economic justification before enterprise adoption.

The region is unlikely to match the West’s percentage growth because the existing endoscopy infrastructure is comparatively mature. Nevertheless, it will remain one of the country’s highest-value markets for premium technologies and clinical innovation.

Midwest

The Midwest represents approximately USD 0.91 billion in 2025 and is projected to reach approximately USD 2.80 billion by 2035, corresponding to an estimated CAGR of approximately 11.9%.

The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota.

Illinois is the largest Midwest market, led by Chicago’s academic hospitals, integrated delivery systems and extensive gastroenterology networks. High endoscopy volumes make the market attractive for AI-assisted colonoscopy and platform upgrades.

Ohio has a particularly strong tertiary-care infrastructure, with Cleveland, Columbus and Cincinnati supporting advanced gastroenterology, colorectal care and clinical research. Cleveland is also relevant to emerging robotic endoscopy research.

Michigan provides significant screening and chronic GI demand across Detroit, Ann Arbor, Grand Rapids and surrounding markets. Academic institutions and large health systems support adoption of advanced technologies while community providers create a broad installed base.

Minnesota has strategic importance because of its medtech heritage and major tertiary referral institutions. The state’s provider ecosystem is receptive to evidence-driven technologies that demonstrate measurable workflow or patient-outcome benefits.

Wisconsin and Indiana support stable procedural demand through large regional health systems, while Missouri has important markets in St. Louis and Kansas City.

Iowa, Kansas and Nebraska have smaller populations but significant regional referral requirements. Smart capsule technologies, connected diagnostics and centralized specialist interpretation can be attractive where patients must travel long distances for advanced GI evaluation.

North Dakota and South Dakota are smaller markets in absolute value but illustrate the access economics of smart gastroenterology. Technologies that allow selected diagnostic steps to occur closer to the patient can reduce travel burden while allowing tertiary specialists to remain involved in interpretation.

The Midwest is likely to be a highly competitive market because health systems frequently emphasize service quality, contracting discipline and demonstrable return on investment. Vendors offering reliable platforms, strong clinical education and attractive enterprise economics should perform well.

Key Market Players

The U.S. Smart Gastroenterology Devices competitive landscape is becoming increasingly multidimensional. Traditional endoscopy leaders retain major advantages through installed equipment bases, physician relationships and service infrastructure, while specialized AI, capsule, digital and robotics companies are creating new competitive layers.

The market is therefore unlikely to develop as a simple contest between conventional endoscopy companies. Instead, competition will increasingly occur among procedure ecosystems, with imaging vendors, AI developers, software companies and therapeutic-device manufacturers forming partnerships or integrating technologies through acquisition.

Some of the key players relevant to the U.S. Smart Gastroenterology Devices industry include:

Olympus Corporation
Medtronic
FUJIFILM Healthcare Americas Corporation
Boston Scientific Corporation
PENTAX Medical / HOYA Corporation
Ambu A/S
CONMED Corporation
Cook Medical
STERIS
Stryker Corporation
KARL STORZ
Laborie Medical Technologies
Diversatek Healthcare
CapsoVision
AnX Robotica
Cosmo Pharmaceuticals / Cosmo Intelligent Medical Devices
Iterative Health
Wision A.I.
Odin Vision / Olympus
Vibrant Gastro
EndoQuest Robotics
EndoSound
Creo Medical
Ovesco Endoscopy
Erbe Elektromedizin

Olympus, Fujifilm, Medtronic and PENTAX are particularly important because endoscopy platform ownership creates direct access to the procedure room. Olympus is strengthening its intelligent endoscopy strategy through cloud-based AI, while Fujifilm combines advanced visualization with its CAD EYE artificial-intelligence platform. Medtronic participates through GI Genius and capsule endoscopy, giving it exposure to both AI-assisted colonoscopy and ingestible imaging.

Specialist technology companies are also important. Iterative Health and Wision A.I. demonstrate that standalone AI developers can compete in computer-aided detection. CapsoVision and AnX Robotica add competition in capsule endoscopy. Vibrant Gastro represents the emerging category of smart ingestible therapy.

EndoQuest Robotics is strategically significant despite the earlier-stage commercial maturity of flexible endoluminal robotics. If clinical development leads to U.S. authorization and successful commercialization, robotics could create a premium segment at the intersection of gastroenterology and minimally invasive surgery.

Over the forecast period, competitive advantage will be influenced by FDA authorization, clinical evidence, physician acceptance, interoperability, installed-base compatibility, cybersecurity, reimbursement support and the ability to demonstrate measurable economic value.

Recent Developments

Recent activity in the U.S. Smart Gastroenterology Devices Market shows that intelligent endoscopy has moved from experimental development into a genuine commercial competition.

In 2024, Fujifilm received U.S. clearance for CAD EYE, expanding the number of AI-assisted colorectal polyp-detection options available to U.S. gastroenterologists. The technology integrates artificial-intelligence functionality with Fujifilm’s endoscopic imaging environment, illustrating the industry’s movement toward embedding intelligence directly within major imaging platforms.

Also in 2024, the U.S. market saw clearance of the CADDIE computer-aided detection platform, developed by Odin Vision within Olympus. Its cloud-based architecture is strategically important because it demonstrates a different deployment model from hardware-centric AI systems. Cloud deployment has the potential to accelerate software updates and enable broader multi-site implementation.

GI Genius continues to evolve as one of the most established U.S. AI-assisted colonoscopy platforms. Newer iterations have expanded hardware compatibility and improved performance characteristics, reinforcing the concept that AI endoscopy products will increasingly have software-style upgrade cycles even when they remain regulated medical devices.

SKOUT and EndoScreener provide additional competitive alternatives, confirming that computer-aided polyp detection is no longer a single-vendor category. This competition should pressure vendors to differentiate around clinically relevant lesion detection, false-positive burden, workflow efficiency and enterprise economics.

Clinical evidence remains a major market-shaping factor. Studies of computer-assisted colonoscopy generally demonstrate improvements in adenoma detection, but U.S. professional guidance has remained appropriately cautious regarding whether current evidence definitively establishes long-term reductions in colorectal cancer incidence or mortality. This is commercially important because health systems will increasingly demand evidence connecting incremental detection to meaningful clinical and economic outcomes.

Cloud-based AI received additional validation from recent clinical research showing improved detection of difficult and high-risk colorectal lesions without major workflow compromise. These findings strengthen the commercial argument for software-based intelligence while also raising the competitive standard for future AI systems.

Capsule technology continues to progress through improved imaging and software. FDA-cleared small-bowel capsule systems from multiple manufacturers provide an increasingly competitive market for non-invasive visualization of the small intestine.

Smart therapeutic capsules have also expanded the definition of intelligent gastroenterology. Programmable vibrating capsule technology for chronic idiopathic constipation demonstrates that ingestible medical devices can influence GI function directly rather than simply collect diagnostic information.

Robotic endoluminal surgery is approaching an important regulatory stage. U.S. clinical investigation of flexible robotic platforms for endoscopic submucosal dissection is evaluating whether robotic control can allow complex colorectal lesions to be removed through natural-orifice access. The technology remains developmental rather than commercially cleared for routine U.S. sale, but successful regulatory progression could create a major new device category later in the forecast period.

The broader trend across these developments is clear: gastroenterology devices are evolving from isolated instruments toward software-upgradable, sensor-enabled and increasingly intelligent procedure platforms.

Conclusion

The U.S. Smart Gastroenterology Devices Market Size & Share is positioned for rapid expansion from approximately USD 5.35 billion in 2025 to USD 16.32 billion by 2035, representing an estimated 11.80% CAGR during 2026–2035.

The market’s growth is supported by a large gastrointestinal disease burden, an expanding colorectal screening population, high U.S. endoscopy volumes, continued growth of ambulatory surgery centers, specialist productivity constraints and rapid innovation in artificial intelligence, capsule devices, advanced visualization and therapeutic endoscopy.

AI-assisted colonoscopy will remain the most visible near-term growth category, but the long-term market should become substantially broader. Smart capsule imaging, ingestible therapy, connected physiologic diagnostics, cloud-based endoscopy intelligence and robotic endoluminal platforms can create new revenue pools that do not exist within traditional endoscopy equipment definitions.

For hospitals and GI organizations, procurement decisions will increasingly center on total procedural value. Detection improvement alone will not guarantee adoption. Buyers will ask whether a technology increases clinically meaningful findings, improves quality consistency, reduces physician workload, preserves procedure throughput, integrates with existing equipment and creates measurable economic benefit.

The competitive advantage of large endoscopy manufacturers will come from installed-base access and the ability to integrate intelligence across broad procedural ecosystems. The advantage of specialist innovators will come from solving narrow clinical or workflow problems substantially better than incumbent platforms.

Regionally, the South will remain the largest market, driven by Texas, Florida and expanding specialty-care infrastructure across fast-growing states. The West should record the fastest growth, led by California and supported by early adoption of digital and AI-driven healthcare technologies. The Northeast will remain the country’s most innovation-intensive and evidence-driven market, while the Midwest will provide a large and economically disciplined installed base for scalable technology adoption.

At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, Minnesota, New Jersey, Virginia and Tennessee will be especially important for market-entry planning, clinical partnerships and commercial expansion.

For clients evaluating this market, the central strategic issue is not simply whether gastroenterology will become more intelligent. That transition is already underway. The more important questions are which technologies will produce enough clinical value to become embedded in standard GI workflow, which vendors will control the intelligent endoscopy ecosystem, how quickly AI and smart devices will penetrate the ASC market, and where robotics and ingestible technologies will create entirely new treatment pathways.

By 2035, the winners in the U.S. Smart Gastroenterology Devices industry are likely to be companies that combine differentiated hardware with validated intelligence, workflow integration, strong clinical evidence and credible procedure-level economics. The market will reward technologies that allow U.S. gastroenterology providers to detect disease earlier, treat patients less invasively, use specialist capacity more effectively and deliver more consistent outcomes across increasingly distributed care networks.

TABLE OF CONTENT

1. U.S. Smart Gastroenterology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Smart Gastroenterology Device Manufacturers
1.6.2. AI, Software, Sensor and Component Technology Providers
1.6.3. Hospital Systems and Integrated Delivery Networks
1.6.4. Gastroenterology Practices and Advanced Endoscopy Centers
1.6.5. Ambulatory Surgery Centers
1.6.6. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.7. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the U.S. smart gastroenterology devices market boundary, study scope, methodology, assumptions and stakeholder ecosystem, allowing clients to understand how AI-assisted endoscopy, smart capsules, connected imaging, robotic systems and intelligent GI diagnostics are measured and validated.

2. U.S. Smart Gastroenterology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas

What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical performance, growth direction, technology adoption, competitive intensity and priority opportunity areas through 2035.

3. U.S. Smart Gastroenterology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Gastrointestinal Disease and Colorectal Cancer Screening Burden
3.1.2. Expansion of AI-Assisted Colonoscopy and Computer-Aided Lesion Detection
3.1.3. Growth of Gastroenterology Procedures in Ambulatory Surgery Centers
3.1.4. Endoscopy Suite Digitalization and Capital Equipment Modernization
3.1.5. Expansion of Capsule Endoscopy, Smart Ingestibles and Advanced Therapeutic Endoscopy

3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost and Uncertain Incremental ROI of Premium Smart GI Technologies
3.2.2. Reimbursement Pressure and Lack of Dedicated Payment for Selected AI Applications
3.2.3. Regulatory, Clinical Evidence and Algorithm Validation Requirements
3.2.4. Interoperability, Cybersecurity and Legacy Endoscopy System Constraints

3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Assisted Adenoma Detection and Endoscopy Quality Standardization
3.3.2. Cloud-Connected Endoscopy Intelligence and Enterprise Analytics
3.3.3. Smart Capsule Imaging and Ingestible Therapeutic Devices
3.3.4. Robotic Endoluminal and Advanced Therapeutic Endoscopy
3.3.5. Outpatient and ASC-Based Smart Gastroenterology Adoption

3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital and ASC Capital Procurement Behavior Analysis

What this section provides: This section explains the clinical, commercial, reimbursement, technology and operational forces shaping U.S. demand, helping clients evaluate adoption drivers, barriers, emerging opportunities and execution risks.

4. U.S. Smart Gastroenterology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Gastroenterology
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Colorectal Cancer Screening Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital and ASC Value Analysis Committee Decision Framework

What this section provides: This section gives clients a comprehensive view of regulation, reimbursement, pricing, supply chain, digital adoption, FDA oversight, technology commercialization and procurement factors affecting the U.S. smart gastroenterology devices industry.

5. U.S. Smart Gastroenterology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. AI-Assisted Endoscopy and Intelligent Detection Systems
5.1.3. Capsule Endoscopy and Smart Ingestible Devices
5.1.4. Connected Advanced Visualization and Imaging Platforms
5.1.5. Robotic and Mechanically Assisted Endoscopic Platforms
5.1.6. Smart Physiologic Diagnostic and Therapeutic Devices

What this section provides: This section identifies the smart gastroenterology product categories expected to generate the largest revenue contribution, highest technology adoption and strongest growth through 2035.

6. U.S. Smart Gastroenterology Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Colorectal Cancer Screening and Polyp Detection
6.1.3. Inflammatory Bowel Disease and Small-Bowel Evaluation
6.1.4. Upper-GI, Hepatobiliary and Pancreatic Disease
6.1.5. GERD, Motility and Functional Gastrointestinal Disorders
6.1.6. Advanced Therapeutic Endoscopy and Endoluminal Intervention

What this section provides: This section evaluates demand according to clinical use case and helps clients identify applications with strong procedure growth, unmet clinical need, reimbursement relevance and potential for intelligent-device adoption.

7. U.S. Smart Gastroenterology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.3. Ambulatory Surgery Centers
7.1.4. Academic Medical Centers and Advanced Gastroenterology Centers
7.1.5. Gastroenterology Practices and Physician Offices
7.1.6. Home-Based and Remote Diagnostic/Therapeutic Users

What this section provides: This section explains which U.S. care settings are expected to drive smart gastroenterology device purchasing, procedure adoption, recurring consumable demand and connected diagnostic utilization.

8. U.S. Smart Gastroenterology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Artificial Intelligence and Computer Vision
8.1.3. Wireless Capsule Imaging and Ingestible Electronics
8.1.4. Cloud-Connected Analytics and Interoperability
8.1.5. Robotic, Mechatronic and Assisted Navigation Technology
8.1.6. Sensor-Based Physiologic Measurement and Smart Therapy

What this section provides: This section assesses the technology platforms redefining U.S. gastroenterology, including AI, computer vision, connected analytics, capsule electronics, robotics and sensor-driven diagnostic and therapeutic technologies.

9. U.S. Smart Gastroenterology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network and Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Medical Device Supplier Sales
9.1.6. ASC and Independent Gastroenterology Practice Procurement

What this section provides: This section explains how smart gastroenterology technologies are purchased in the United States, including health-system contracting, IDN standardization, GPO influence, distributor participation and ASC/private-practice procurement behavior.

10. U.S. Smart Gastroenterology Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional GI Procedure Volume, ASC and Hospital Infrastructure Analysis
10.1.4. Regional Reimbursement, Technology Adoption and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Smart Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Smart Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Smart Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Smart Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and 50-state analysis, allowing clients to identify priority U.S. geographies, GI procedure hubs, ASC concentration, AI and smart-device adoption hotspots, hospital infrastructure, procurement patterns and state-level commercial opportunities.

11. U.S. Smart Gastroenterology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players

11.3. Company Profiles

11.3.1. Olympus Corporation
11.3.2. Medtronic
11.3.3. FUJIFILM Healthcare Americas Corporation
11.3.4. PENTAX Medical / HOYA Corporation
11.3.5. Boston Scientific Corporation
11.3.6. Ambu A/S
11.3.7. Stryker Corporation
11.3.8. KARL STORZ
11.3.9. CONMED Corporation
11.3.10. Cook Medical
11.3.11. STERIS
11.3.12. Laborie Medical Technologies
11.3.13. Diversatek Healthcare
11.3.14. CapsoVision
11.3.15. AnX Robotica
11.3.16. Cosmo Intelligent Medical Devices
11.3.17. Iterative Health
11.3.18. Wision A.I.
11.3.19. Magentiq Eye
11.3.20. Vibrant Gastro
11.3.21. EndoQuest Robotics
11.3.22. EndoSound
11.3.23. Creo Medical
11.3.24. Ovesco Endoscopy
11.3.25. Erbe Elektromedizin

Note: Each company profile will include company overview, U.S. smart gastroenterology product portfolio, AI/digital capabilities, market strategy, financial positioning where applicable, clinical pipeline, FDA and regulatory updates, partnerships, acquisitions and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, platform positioning, AI and digital capability assessment, innovation direction and strategic intelligence on established and emerging smart gastroenterology device companies.

12. U.S. Smart Gastroenterology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Endoscopy and Next-Generation CADe/CADx
12.2.2. Cloud-Connected Endoscopy Intelligence and Enterprise Analytics
12.2.3. Smart Capsule Imaging and Ingestible Electronics
12.2.4. Robotic Endoluminal Intervention and Advanced Therapeutic Endoscopy
12.2.5. Sensor-Enabled Physiologic Diagnostics and Smart GI Therapeutics

12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix

What this section provides: This section prepares clients for technology disruption, future adoption scenarios, business-model evolution, investment opportunities and likely changes in the U.S. smart gastroenterology device ecosystem through 2035.

13. U.S. Smart Gastroenterology Devices Market: Strategic Recommendations

13.1. Recommendations for Smart Gastroenterology Device Manufacturers
13.2. Recommendations for Hospitals, Health Systems and Ambulatory Surgery Centers
13.3. Recommendations for Investors and Private Equity Firms
13.4. Recommendations for Distributors, GPOs and Technology Channel Partners
13.5. Recommendations for New Entrants, AI Developers and Medtech Startups
13.6. U.S. Go-to-Market Strategy Considerations
13.7. Product Positioning, Platform Integration and Portfolio Expansion Guidance

What this section provides: This section converts market intelligence into actionable strategies for commercial expansion, product positioning, hospital and ASC market access, investment prioritization, channel development and competitive differentiation.

14. U.S. Smart Gastroenterology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope limitations, forecasting assumptions, legal boundaries, third-party data considerations and permitted interpretation of market estimates.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Smart Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Smart Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Smart Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Smart Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Smart Gastroenterology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Smart Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Smart Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Smart Gastroenterology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Smart Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Smart Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Smart Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Smart Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Smart Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Smart Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Smart Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Smart Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Smart Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Smart Gastroenterology Devices Market: Hospital and ASC Capital Procurement Behavior Matrix
TABLE 20: U.S. Smart Gastroenterology Devices Market: PESTEL Analysis
TABLE 21: U.S. Smart Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Smart Gastroenterology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Smart Gastroenterology Devices Market: Value Chain Analysis
TABLE 24: U.S. Smart Gastroenterology Devices Market: Supply Chain Analysis
TABLE 25: U.S. Smart Gastroenterology Devices Market: Digitalization and Connected Gastroenterology Impact
TABLE 26: U.S. Smart Gastroenterology Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Smart Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Smart Gastroenterology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Smart Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Smart Gastroenterology Devices Market: Government Initiatives and Colorectal Cancer Screening Programs
TABLE 31: U.S. Smart Gastroenterology Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Smart Gastroenterology Devices Market: Hospital and ASC Value Analysis Committee Decision Framework
TABLE 33: U.S. Smart Gastroenterology Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Smart Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Smart Gastroenterology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Smart Gastroenterology Devices Market: AI-Assisted Endoscopy and Intelligent Detection Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Smart Gastroenterology Devices Market: Capsule Endoscopy and Smart Ingestible Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Smart Gastroenterology Devices Market: Connected Advanced Visualization and Imaging Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Smart Gastroenterology Devices Market: Robotic and Mechanically Assisted Endoscopic Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Smart Gastroenterology Devices Market: Smart Physiologic Diagnostic and Therapeutic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Smart Gastroenterology Devices Market: Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Application
TABLE 44: U.S. Smart Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Smart Gastroenterology Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 46: U.S. Smart Gastroenterology Devices Market: Colorectal Cancer Screening and Polyp Detection Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Smart Gastroenterology Devices Market: Inflammatory Bowel Disease and Small-Bowel Evaluation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Smart Gastroenterology Devices Market: Upper-GI, Hepatobiliary and Pancreatic Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Smart Gastroenterology Devices Market: GERD, Motility and Functional Gastrointestinal Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Smart Gastroenterology Devices Market: Advanced Therapeutic Endoscopy and Endoluminal Intervention Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Smart Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by End User
TABLE 53: U.S. Smart Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 54: U.S. Smart Gastroenterology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 55: U.S. Smart Gastroenterology Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Smart Gastroenterology Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Smart Gastroenterology Devices Market: Academic Medical Centers and Advanced Gastroenterology Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Smart Gastroenterology Devices Market: Gastroenterology Practices and Physician Offices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Smart Gastroenterology Devices Market: Home-Based and Remote Diagnostic/Therapeutic Users Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Smart Gastroenterology Devices Market: Technology Type Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 62: U.S. Smart Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 63: U.S. Smart Gastroenterology Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 64: U.S. Smart Gastroenterology Devices Market: Artificial Intelligence and Computer Vision Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Smart Gastroenterology Devices Market: Wireless Capsule Imaging and Ingestible Electronics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Smart Gastroenterology Devices Market: Cloud-Connected Analytics and Interoperability Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Smart Gastroenterology Devices Market: Robotic, Mechatronic and Assisted Navigation Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Smart Gastroenterology Devices Market: Sensor-Based Physiologic Measurement and Smart Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Smart Gastroenterology Devices Market: Procurement Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 71: U.S. Smart Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Smart Gastroenterology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 73: U.S. Smart Gastroenterology Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Smart Gastroenterology Devices Market: Integrated Delivery Network and Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Smart Gastroenterology Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Smart Gastroenterology Devices Market: Distributor and Specialty Medical Device Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Smart Gastroenterology Devices Market: ASC and Independent Gastroenterology Practice Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Smart Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Smart Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Smart Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Smart Gastroenterology Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Smart Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Smart Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Smart Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Smart Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Smart Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Smart Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Smart Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: California Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Washington Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Arizona Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Colorado Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Oregon Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Utah Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Nevada Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: New Mexico Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Idaho Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Montana Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Wyoming Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Alaska Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Hawaii Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Northeast Region U.S. Smart Gastroenterology Devices Market: Regional Overview and Trends
TABLE 104: Northeast Region U.S. Smart Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 105: Northeast Region U.S. Smart Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 106: Northeast Region U.S. Smart Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 107: Northeast Region U.S. Smart Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: Northeast Region U.S. Smart Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Smart Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 110: Northeast Region U.S. Smart Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 111: New York Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Massachusetts Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: New Jersey Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Pennsylvania Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Connecticut Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Maine Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Vermont Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: New Hampshire Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Rhode Island Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Delaware Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: South Region U.S. Smart Gastroenterology Devices Market: Regional Overview and Trends
TABLE 122: South Region U.S. Smart Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 123: South Region U.S. Smart Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 124: South Region U.S. Smart Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 125: South Region U.S. Smart Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 126: South Region U.S. Smart Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: South Region U.S. Smart Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Smart Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 129: Texas Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Florida Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Georgia Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: North Carolina Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Tennessee Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: South Carolina Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Alabama Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Mississippi Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Louisiana Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Arkansas Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Kentucky Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Oklahoma Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Virginia Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Maryland Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: West Virginia Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Midwest Region U.S. Smart Gastroenterology Devices Market: Regional Overview and Trends
TABLE 145: Midwest Region U.S. Smart Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 146: Midwest Region U.S. Smart Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 147: Midwest Region U.S. Smart Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region U.S. Smart Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 149: Midwest Region U.S. Smart Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region U.S. Smart Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Smart Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 152: Illinois Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Ohio Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Michigan Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Minnesota Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Indiana Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Wisconsin Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Missouri Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Iowa Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Kansas Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Nebraska Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: North Dakota Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: South Dakota Smart Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: U.S. Smart Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 165: U.S. Smart Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 166: U.S. Smart Gastroenterology Devices Market: Company Positioning Matrix
TABLE 167: U.S. Smart Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 168: U.S. Smart Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 169: Olympus Corporation: Company Profile
TABLE 170: Medtronic: Company Profile
TABLE 171: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 172: PENTAX Medical / HOYA Corporation: Company Profile
TABLE 173: Boston Scientific Corporation: Company Profile
TABLE 174: Ambu A/S: Company Profile
TABLE 175: Stryker Corporation: Company Profile
TABLE 176: KARL STORZ: Company Profile
TABLE 177: CONMED Corporation: Company Profile
TABLE 178: Cook Medical: Company Profile
TABLE 179: STERIS: Company Profile
TABLE 180: Laborie Medical Technologies: Company Profile
TABLE 181: Diversatek Healthcare: Company Profile
TABLE 182: CapsoVision: Company Profile
TABLE 183: AnX Robotica: Company Profile
TABLE 184: Cosmo Intelligent Medical Devices: Company Profile
TABLE 185: Iterative Health: Company Profile
TABLE 186: Wision A.I.: Company Profile
TABLE 187: Magentiq Eye: Company Profile
TABLE 188: Vibrant Gastro: Company Profile
TABLE 189: EndoQuest Robotics: Company Profile
TABLE 190: EndoSound: Company Profile
TABLE 191: Creo Medical: Company Profile
TABLE 192: Ovesco Endoscopy: Company Profile
TABLE 193: Erbe Elektromedizin: Company Profile
TABLE 194: U.S. Smart Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 195: U.S. Smart Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 196: U.S. Smart Gastroenterology Devices Market: Emerging Business Trends
TABLE 197: U.S. Smart Gastroenterology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 198: U.S. Smart Gastroenterology Devices Market: Investment Prioritization Matrix
TABLE 199: U.S. Smart Gastroenterology Devices Market: Strategic Recommendations for Smart Gastroenterology Device Manufacturers
TABLE 200: U.S. Smart Gastroenterology Devices Market: Strategic Recommendations for Hospitals, Health Systems and Ambulatory Surgery Centers
TABLE 201: U.S. Smart Gastroenterology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 202: U.S. Smart Gastroenterology Devices Market: Strategic Recommendations for Distributors, GPOs and Technology Channel Partners
TABLE 203: U.S. Smart Gastroenterology Devices Market: Strategic Recommendations for New Entrants, AI Developers and Medtech Startups
TABLE 204: U.S. Smart Gastroenterology Devices Market: U.S. Go-to-Market Strategy Considerations
TABLE 205: U.S. Smart Gastroenterology Devices Market: Product Positioning, Platform Integration and Portfolio Expansion Guidance
TABLE 206: U.S. Smart Gastroenterology Devices Market: Scope Limitation
TABLE 207: U.S. Smart Gastroenterology Devices Market: Data Use Limitation
TABLE 208: U.S. Smart Gastroenterology Devices Market: Forecasting Limitation
TABLE 209: U.S. Smart Gastroenterology Devices Market: Legal Disclaimer
TABLE 210: U.S. Smart Gastroenterology Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Smart Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Smart Gastroenterology Devices Market Ecosystem
FIGURE 4: U.S. Smart Gastroenterology Devices Market Stakeholder Map
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. Smart Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Smart Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. Smart Gastroenterology Devices Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital and ASC Capital Procurement Decision Framework
FIGURE 13: PESTEL Analysis
FIGURE 14: Porter’s Five Forces Analysis
FIGURE 15: Value Chain Analysis
FIGURE 16: Supply Chain Analysis
FIGURE 17: Digitalization and Connected Gastroenterology Impact Framework
FIGURE 18: FDA Regulatory and CMS Reimbursement Landscape
FIGURE 19: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 20: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: AI-Assisted Endoscopy and Intelligent Detection Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Capsule Endoscopy and Smart Ingestible Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Connected Advanced Visualization and Imaging Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Robotic and Mechanically Assisted Endoscopic Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Smart Physiologic Diagnostic and Therapeutic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Colorectal Cancer Screening and Polyp Detection Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Inflammatory Bowel Disease and Small-Bowel Evaluation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Upper-GI, Hepatobiliary and Pancreatic Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: GERD, Motility and Functional Gastrointestinal Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Advanced Therapeutic Endoscopy and Endoluminal Intervention Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 34: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Academic Medical Centers and Advanced Gastroenterology Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Gastroenterology Practices and Physician Offices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Home-Based and Remote Diagnostic/Therapeutic Users Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Artificial Intelligence and Computer Vision Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Wireless Capsule Imaging and Ingestible Electronics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Cloud-Connected Analytics and Interoperability Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Robotic, Mechatronic and Assisted Navigation Technology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Sensor-Based Physiologic Measurement and Smart Therapy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Integrated Delivery Network and Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Distributor and Specialty Medical Device Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: ASC and Independent Gastroenterology Practice Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Smart Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. Smart Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Delaware Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: South Region U.S. Smart Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Florida Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Georgia Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: North Carolina Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Tennessee Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Carolina Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Alabama Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Mississippi Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Louisiana Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Arkansas Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Kentucky Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Oklahoma Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Virginia Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Maryland Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: West Virginia Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Midwest Region U.S. Smart Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 104: Midwest Region Market Share Analysis by State, 2025
FIGURE 105: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota Smart Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Product Portfolio Benchmarking
FIGURE 121: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 122: U.S. Smart Gastroenterology Devices Innovation Roadmap
FIGURE 123: AI-Assisted Endoscopy and CADe/CADx Adoption Roadmap
FIGURE 124: Smart Capsule and Ingestible Technology Opportunity Map
FIGURE 125: Robotic Endoluminal Intervention Development Roadmap
FIGURE 126: Future Market Scenario Analysis, 2026–2035
FIGURE 127: Disruptive Technologies Impact Matrix
FIGURE 128: Emerging Business Trends Matrix
FIGURE 129: Investment Prioritization Matrix
FIGURE 130: Strategic Growth Roadmap for U.S. Smart Gastroenterology Device Companies
FIGURE 131: U.S. Go-to-Market Strategy Framework
FIGURE 132: Product Positioning, Platform Integration and Portfolio Expansion Framework
FIGURE 133: Report Scope and Disclaimer Framework